Repetitive transcranial magnetic stimulation of the primary motor cortex in the treatment of motor signs in Parkinson's disease: A quantitative review of the literature

Movement Disorders

Volumn 30, Issue 6, 2015, Pages 750-758

  Zanjani, Anosha ^a   Zakzanis, Konstantine K ^a   Daskalakis, Zafiris J ^a   Chen, Robert ^b  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

Meta analysis; Parkinson's disease; Review; Transcranial magnetic stimulation (rTMS); Treatment efficacy

Indexed keywords

ARTICLE; CLINICAL EVALUATION; EFFECT SIZE; FOLLOW UP; GENERAL CONDITION IMPROVEMENT; HUMAN; LONG TERM CARE; META ANALYSIS; MOTOR PERFORMANCE; NERVE STIMULATION; PARKINSON DISEASE; PLACEBO EFFECT; PRIMARY MOTOR CORTEX; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SYSTEMATIC REVIEW; THERAPY EFFECT; TRANSCRANIAL MAGNETIC STIMULATION; TREATMENT OUTCOME; TREATMENT RESPONSE; UNIFIED PARKINSON DISEASE RATING SCALE; MOTOR ACTIVITY; MOTOR CORTEX; PATHOPHYSIOLOGY; PROCEDURES; TIME;

HUMANS; MOTOR ACTIVITY; MOTOR CORTEX; PARKINSON DISEASE; TIME FACTORS; TRANSCRANIAL MAGNETIC STIMULATION; TREATMENT OUTCOME;

EID: 84929653437     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.26206     Document Type: Article

References (33)

1. Schapira AH. Science, medicine, and the future: Parkinson's disease. BMJ 1999;318:311-314.
2. Benninger DH, Iseki K, Kranick S, Luckenbaugh DA, Houdayer E, Hallett M. Controlled study of 50-Hz repetitive transcranial magnetic stimulation for the treatment of Parkinson disease. Neurorehabil Neural Repair 2012;26:1096-1105.
3. Lefaucheur JP, Drouot X, Von Raison F, Menard-Lefaucheur I, Cesaro P, Nguyen JP. Improvement of motor performance and modulation of cortical excitability by repetitive transcranial magnetic stimulation of the motor cortex in Parkinson's disease. Clin Neurophysiol 2004;115:2530-2541.
4. Benninger DH, Berman BD, Houdayer E, et al. Intermittent theta-burst transcranial magnetic stimulation for treatment of Parkinson disease. Neurology 2011;76:601-609.
5. Maertens de Noordhout A. General principles for clinical use of repetitive transcranial magnetic stimulation (rTMS). Neurophysiol Clin 2006;36:97-103.
6. Lefaucheur JP. Principles of therapeutic use of transcranial and epidural cortical stimulation. Clin Neurophysiol 2008;119:2179-2184.
7. Filipovic SR, Rothwell JC, Bhatia K. Low-frequency repetitive transcranial magnetic stimulation and off-phase motor symptoms in Parkinson's disease. J Neurol Sci 2010;291:1-4.
8. Gonzalez-Garcia N, Armony JL, Soto J, Trejo D, Alegria MA, Drucker-Colin R. Effects of rTMS on Parkinson's disease: a longitudinal fMRI study. J Neurol 2011;258:1268-1280.
9. Arias P, Vivas J, Grieve KL, Cudeiro J. Controlled trial on the effect of 10 days low-frequency repetitive transcranial magnetic stimulation (rTMS) on motor signs in Parkinson's disease. Mov Disord 2010;25:1830-1838.
10. Elahi B, Chen R. Effect of transcranial magnetic stimulation on Parkinson motor function: systematic review of controlled clinical trials. Mov Disord 2009;24:357-363.
11. Fregni F, Simon DK, Wu A, Pascual-Leone A. Non-invasive brain stimulation for Parkinson's disease: a systematic review and meta-analysis of the literature. J Neurol Neurosurg Psychiatry 2005;76:1614-1623.
12. Movement Disorder Society Task Force on Rating Scales for Parkinson's D. The Unified Parkinson's Disease Rating Scale (UPDRS): status and recommendations. Mov Disord 2003;18:738-750.
13. Martinez-Martin P, Gil-Nagel A, Gracia LM, Gomez JB, Martinez-Sarries J, Bermejo F. Unified Parkinson's Disease Rating Scale characteristics and structure. The Cooperative Multicentric Group. Mov Disord 1994;9:76-83.
14. Curtin F, Altman DG, Elbourne D. Meta-analysis combining parallel and cross-over clinical trials. I: Continuous outcomes. Stat Med 2002;21:2131-2144.
15. Cohn J. Statistical Power Analysis for the Behavioral Sciences. 2nd ed. Hillsdale, NJ: Lawrence Erlbaum Associates, 1988.
16. Zakzanis KK. Brain is related to behavior (p<.05). J Clin Exp Neuropsychol 1998;20:419-427.
17. Zakzanis KK. Statistics to tell the truth, the whole truth, and nothing but the truth: formulae, illustrative numerical examples, and heuristic interpretation of effect size analyses for neuropsychological researchers. Arch Clin Neuropsychol 2001;16:653-667.
18. Shulman LM, Gruber-Baldini AL, Anderson KE, Fishman PS, Reich SG, Weiner WJ. The clinically important difference on the unified Parkinson's disease rating scale. Arch Neurol 2010;67:64-70.
19. Khedr EM, Farweez HM, Islam H. Therapeutic effect of repetitive transcranial magnetic stimulation on motor function in Parkinson's disease patients. Eur J Neurol 2003;10:567-572.
20. Lomarev MP, Kanchana S, Bara-Jimenez W, Iyer M, Wassermann EM, Hallett M. Placebo-controlled study of rTMS for the treatment of Parkinson's disease. Mov Disord 2006;21:325-331.
21. Okabe S, Ugawa Y, Kanazawa I. Effectiveness of r TMSoPsDSG: 0.2-Hz repetitive transcranial magnetic stimulation has no add-on effects as compared to a realistic sham stimulation in Parkinson's disease. Mov Disord 2003;18:382-388.
22. Siebner HR, Rossmeier C, Mentschel C, Peinemann A, Conrad B. Short-term motor improvement after sub-threshold 5-Hz repetitive transcranial magnetic stimulation of the primary motor hand area in Parkinson's disease. J Neurol Sci 2000;178:91-94.
23. Bornke C, Schulte T, Przuntek H, Muller T. Clinical effects of repetitive transcranial magnetic stimulation versus acute levodopa challenge in Parkinson's disease. J Neural Transm Suppl 2004;68:61-67.
24. Kaptchuk TJ, Goldman P, Stone DA, Stason WB. Do medical devices have enhanced placebo effects? J Clin Epidemiol 2000;53:786-792.
25. Tsuji S, Akamatsu N. Does transcranial magnetic stimulation improve the motor symptoms of Parkinson disease? J Neurol 2003;250(Suppl 3):III47-50.
26. Strafella AP, Paus T, Fraraccio M, Dagher A. Striatal dopamine release induced by repetitive transcranial magnetic stimulation of the human motor cortex. Brain 2003;126:2609-2615.
27. Strafella AP, Ko JH, Grant J, Fraraccio M, Monchi O. Corticostriatal functional interactions in Parkinson's disease: a rTMS/[11C]raclopride PET study. Eur J Neurosci 2005;22:2946-2952.
28. Pascual-Leone A, Valls-Sole J, Wassermann EM, Hallett M. Responses to rapid-rate transcranial magnetic stimulation of the human motor cortex. Brain 1994;117:847-858.
29. Chen R, Classen J, Gerloff C, et al. Depression of motor cortex excitability by low-frequency transcranial magnetic stimulation. Neurology 1997;48:1398-1403.
30. Kazdin AE. The meanings and measurement of clinical significance. J Consult Clin Psychol 1999;67:332-339.
31. Pascual-Leone A, Valls-Sole J, Brasil-Neto JP, Cohen LG, Hallett M. Akinesia in Parkinson's disease. I. Shortening of simple reaction time with focal, single-pulse transcranial magnetic stimulation. Neurology 1994;44:884-891.
32. Helmich RC, Siebner HR, Bakker M, Munchau A, Bloem BR. Repetitive transcranial magnetic stimulation to improve mood and motor function in Parkinson's disease. J Neurol Sci 2006;248:84-96.
33. Kleim JA, Chan S, Pringle E, et al. BDNF val66met polymorphism is associated with modified experience-dependent plasticity in human motor cortex. Nat Neurosci 2006;9:735-737.